Stockreport

Precision BioSciences Completes License Deal with TG Therapeutics for Cell Therapy Azer-Cel in Treatment of Autoimmune Diseases [Yahoo! Finance]

Precision BioSciences, Inc.  (DTIL) 
Last precision biosciences, inc. earnings: 11/12 07:15 am Check Earnings Report
PDF Upfront Cash and Near-Term Payments Expected to Extend Precision's Cash Runway into the First Half of 2026 and Fund Precision's Wholly-Owned In Vivo Gene Editing Progra [Read more]